
Overview
Grindeks Kalceks Polska is a representative office of the pharmaceutical group Grindeks, based in Warsaw and established in 2023. It offers medicines under the Grindeks and Kalceks brands, covering hospital care (including anaesthesiology, oncology and neurology) and outpatient care, mainly cardiology, neurology and gastroenterology. The group has operated since 1946, is headquartered in Riga, Latvia, and sells its products in 100 countries.
Financials
Revenue history (in k)
From the notes
| Profit allocation | No decision | |
| Loans and borrowings | 1 items | |
| Revenue structure | Sprzedaż produktów | |
| Management board pay | $55,359 | |
| Related parties | 2 items | |
| Parent company | Akciju Sabiedriba GRINDEKS |
Filing timeliness
1 of 3 financial statements was filed late (for 2024, 178 days late).
- 202527/05/2026
- 202409/01/2026
- 202309/05/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Original medicines
- Generic medicines
- Active ingredients
- Cardiology products
- Neurological products
- Oncology products
- Diabetes products
- Dermatological products
Websites
The company has 11 websites, including 9 versions for foreign markets (e.g. Germany, Netherlands, Australia). All of them run on WordPress.
- grindeks.plStrona główna – Grindeks PolandWordPress 7.1Google Tag ManagerRRank MathWWPMLNginx
- grindeks.beStartpagina - Grindeks BelgiumWordPress 7.1Google Tag ManagerRRank MathWWPMLCloudflare
- grindeks.comHome page | GrindeksWordPress 7.1Google Tag ManagerRRank MathWWPMLCloudflare
Job offers
The company lists many job openings on its own careers page: grindeks.com/en/career. The first ones are below.
Authorized Representatives
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Akciju Sabiedriba Grindeks | 8,700 | $117,504.05 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Akciju sabiedriba "GRINDEKS" (Latvia) group, which is its direct owner. The group has 3 companies, 2 of them abroad.
| Name | Country |
|---|---|
| Akciju sabiedriba "Kalceks" | |
| Tallinna Farmaatsiatehase Aktsiaselts |
Bank accounts
Registered as a VAT taxpayer on 2023-04-01.
58 1240 6292 1978 0011 3874 2510
80 1240 6292 1111 0011 3874 2493
89 2370 0008 0000 0000 2103 7021
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl | ||
| Orion Pharma Poland sp. z o.o. | $13,123,658.19 | orionpharma.pl | ||
| +Pharma Polska sp. z o.o. | $11,985,446.19 | pluspharma.pl | ||
| Ibsa Poland sp. z o.o. | $8,664,746.04 | ibsapoland.pl | ||
| Inpharm Services sp. z o.o. + limited partnership | $5,857,488.91 | inpharm.pl | ||
| Bioton Marketing Agency sp. z o.o. | $5,754,696.88 | bioton.com | ||
| Noris Polska sp. z o.o. | $4,417,954.24 | norispolska.pl | ||
| Komtur Care sp. z o.o. | $3,471,033.23 | komtur.pl | ||
| GWS Poland sp. z o.o. | $2,706,990.11 | gwspoland.pl | ||
| Pube Global sp. z o.o. | $1,777,827.09 | pubeglobal.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-29 | Share capital increase (5,000.00 PLN → 435,000.00 PLN) | |
| 2023-06-12 | Address change (Ul. Twarda 18, 00-105, Warszawa → Ul. Wiktorii Wiedeńskiej 9a/62, 02-954, Warszawa) | |
| 2023-03-03 | Address change (Ul. Chłodna 51, 00-867, Warszawa → Ul. Twarda 18, 00-105, Warszawa) | |
| 2022-07-22 | Entered in the register |
FAQ
Last updated: 2026-10-07